Improving access to medicines for people with rare diseases

Our Vision

The vision of AFT Orphan is to be the leading company in Southeast Asia providing access to orphan medicines for patients suffering from rare diseases.

More specifically, we:

  • provide a low-risk and cost-effective solution for biotech companies with commercialised orphan drugs to access our markets of expertise
  • leverage established infrastructure and widespread industry expertise to ensure rapid patient and physician access to important life changing therapies
  • build custom solutions for the ethical medical promotion of orphan drugs (which can include central teams operating regionally and/or individual country sales)

We provide reassurance to partners that our promotion of orphan treatments will be ethical and backed by ‘best-in-class’ operations, supply chain and pharmaco-vigilance.


Our Competitive Advantage

The AFT Orphan competitive advantage is that we can leverage a unique depth of functional experience within the team.

With fully established capabilities in research and development, clinical trial database management (patient registries), regulatory, supply chain and pharmaco-vigilance, we provide the ideal base to build a bespoke medical/marketing organisation to maximise orphan success across the region.

To discuss further, please contact us.